Search
Descriptor English: Antitubercular Agents
Descriptor Spanish: Antituberculosos
Descriptor antituberculosos
Entry term(s) agente antituberculoso
agente tuberculostático
agentes antituberculosos
antituberculoso
fármaco tuberculostático
fármaco antituberculoso
fármacos antituberculosos
tuberculostático
tuberculostáticos
Scope note: Fármacos que se utilizan en el tratamiento de la tuberculosis. Se dividen en dos clases principales: los fármacos de "primera línea", que son aquellos con la mayor eficacia y el grado más aceptable de toxicidad y se usan satisfactoriamente en la gran mayoría de los casos, y los fármacos de "segunda línea", utilizados en casos de farmacorresistencia o en los que otra condición relacionada con el paciente ha reducido la eficacia del tratamiento primario.
Descriptor Portuguese: Antituberculosos
Descriptor French: Antituberculeux
Entry term(s): Agent, Anti-Tuberculosis
Agent, Antitubercular
Agent, Tuberculostatic
Agents, Antitubercular
Agents, Tuberculostatic
Anti Tuberculosis Agent
Anti Tuberculosis Agents
Anti Tuberculosis Drug
Anti Tuberculosis Drugs
Anti-Tuberculosis Agent
Anti-Tuberculosis Agents
Anti-Tuberculosis Drug
Anti-Tuberculosis Drugs
Antitubercular Agent
Antitubercular Drug
Antitubercular Drugs
Drug, Anti-Tuberculosis
Drug, Antitubercular
Drugs, Antitubercular
Tuberculostatic Agent
Tuberculostatic Agents
Tree number(s): D27.505.954.122.085.255
RDF Unique Identifier: https://id.nlm.nih.gov/mesh/D000995
Scope note: Drugs used in the treatment of tuberculosis. They are divided into two main classes: "first-line" agents, those with the greatest efficacy and acceptable degrees of toxicity used successfully in the great majority of cases; and "second-line" drugs used in drug-resistant cases or those in which some other patient-related condition has compromised the effectiveness of primary therapy.
Annotation: consider also MYCOBACTERIUM TUBERCULOSIS /drug eff & TUBERCULOSIS /drug ther
Allowable Qualifiers: AD administration & dosage
AE adverse effects
AG agonists
AI antagonists & inhibitors
AN analysis
BL blood
CF cerebrospinal fluid
CH chemistry
CL classification
CS chemical synthesis
EC economics
HI history
IM immunology
IP isolation & purification
ME metabolism
PD pharmacology
PK pharmacokinetics
PO poisoning
RE radiation effects
SD supply & distribution
ST standards
TO toxicity
TU therapeutic use
UR urine
Related: Tuberculosis MeSH
Tuberculosis, Multidrug-Resistant MeSH
DeCS ID: 999
Unique ID: D000995
Documents indexed in the Virtual Health Library (VHL): Click here to access the VHL documents
Date Established: 1966/01/01
Date of Entry: 1999/01/01
Revision Date: 2020/01/16
Antitubercular Agents - Preferred
Concept UI M0001515
Scope note Drugs used in the treatment of tuberculosis. They are divided into two main classes: "first-line" agents, those with the greatest efficacy and acceptable degrees of toxicity used successfully in the great majority of cases; and "second-line" drugs used in drug-resistant cases or those in which some other patient-related condition has compromised the effectiveness of primary therapy.
Preferred term Antitubercular Agents
Entry term(s) Agent, Anti-Tuberculosis
Agent, Antitubercular
Agent, Tuberculostatic
Agents, Antitubercular
Agents, Tuberculostatic
Anti Tuberculosis Agent
Anti Tuberculosis Agents
Anti Tuberculosis Drug
Anti Tuberculosis Drugs
Anti-Tuberculosis Agent
Anti-Tuberculosis Agents
Anti-Tuberculosis Drug
Anti-Tuberculosis Drugs
Antitubercular Agent
Antitubercular Drug
Antitubercular Drugs
Drug, Anti-Tuberculosis
Drug, Antitubercular
Drugs, Antitubercular
Tuberculostatic Agent
Tuberculostatic Agents



We want your feedback on the new DeCS / MeSH website

We invite you to complete a survey that will take no more than 3 minutes.

Go to survey